Expansion of the EL-22 and EL-32 IP Portfolio The EL-22 application includes claims directed to pharmaceutical product approaches involving myostatin-derived Myo-2 peptide constructs for potential use in preserving lean muscle mass in humans
Opt for a variety of protein sources, including lean meats, plant-based proteins, and dairy, to ensure a broad spectrum of essential amino acids
Your semaglutide provider will assess your full medical history, existing medications, and lifestyle to develop a plan individualized for you
Pros: Targets calorie absorption directly in the digestive tract
We look forward to helping you achieve a transformation that feels both safe and permanent
Critical Reviews in Food Science and Nutrition, 59 (7), 11241136